Nausea from chemotherapy, treatment

He noted that he had absolutely no side effects from the chemotherapy when he was also being treated with the hydrogen peroxide. D.P. said, "When you would leave town, I would always have trouble with the chemotherapy with nausea, vomiting and very severe depression." His doctors, he said, were puzzled that he had so little in the way of side effects from most of the treatment. D.P. said he also felt extremely fatigued and spent a great deal of time in bed when he would take the chemotherapy treatment without having had the peroxide. 

Activation of 5-HT3 receptors elicits prominent pharmacological responses from the cardiovascular and respiratory systems and from the gastrointestinal tract [Fozard 1992). Several 5-FIT3 receptor antagonists have been marketed for the treatment of nausea and vomiting associated with cancer chemotherapy and radiotherapy [Bunce et al. 1991). 

The FDA, in 1985, gave approval for the use of two psychoactive chemicals from marijuana to prevent nausea and vomiting after chemotherapy in cancer treatment. THC can be prescribed in capsule form for these patients. Research suggests that compounds, other than THC, inhaled when smoking marijuana can also be used for medicinal purposes. Marijuana may help stop the weight loss in AIDS patients, it might lower eye pressnre in people with glaucoma, it may control spasms in multiple sclerosis patients, and it could be used to relieve chronic pain. 

Nausea, vomiting and loss of appetite may occur during treatment. Chlorambucil chemotherapy may cause a temporary reduction in the production of blood cells by the bone marrow. Reduction in blood cells can result in anemia, risk of bruising or bleeding, and infection. This effect can begin from 10 to 14 days after the treatment has been given and may last for a few days. The extent to which the blood cell count is reduced depends on the dose of... 

Sesame oU solubilizes 2.5 mg, 5 mg or 10 mg dronabinol, also known as A-9-tetrahydrocannabinol, in Marinol soft gelatin capsules. Dronabinol is the principal psychoactive component of cannabis and hnds therapeutic application as an anti-emetic for treatment of the nausea and vomiting associated with cancer chemotherapy or as an appetite stimulant to treat AIDS wasting syndrome. Dronabinol exists as a hydrophobic oil at ambient room temperature, and after oral administration is almost completely absorbed (90-95%). However, the bioavailability of dronabinol is only about 10-20% due to extensive hepatic hrst-pass metabolism. The dose of dronabinol is 2.5-10 mg (one capsule) twice daily. Marinol soft gelatin capsules should be stored at 8-15° C and must be protected from freezing. Marinol is available in the USA. 

---